Literature DB >> 17408692

No association found between the promoter variants of ADRA1A and schizophrenia in the Chinese population.

Ke Huang1, Yongyong Shi, Wei Tang, Ruqi Tang, Shengzhen Guo, Yifeng Xu, Junwei Meng, Xingwang Li, Guoying Feng, Lin He.   

Abstract

Schizophrenia is a chronic psychiatry disorder with a strong genetic component. A recent association study of alpha(1A)-adrenoceptor gene (ADRA1A) involving an isolated Spanish population, focusing on the promoter region of the ADRA1A, genotyped eight single SNPs at the promoter region of ADRA1A and found that two SNPs, -563G/A and -9625G/A, were associated with schizophrenia and schizoaffective disorders. We were interested in the two positive sites reported and selected five variants among the promoter region of ADRA1A, namely -563G/A, -9625G/A, -2760C/A, -4155G/C and a new substitution we detected between -508bp and -530bp upstream of the translation initiation site. Our sample consisted of 480 schizophrenia and 480 control subjects. All recruits were Han Chinese in Shanghai origin. However, neither individual SNP nor any haplotype was associated with schizophrenia in our study. These results suggest that the variants among the promoter of ADRA1A gene are unlikely to play a major role in the susceptibility to schizophrenia in the Chinese population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17408692     DOI: 10.1016/j.jpsychires.2007.02.008

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  2 in total

1.  Preliminary evidence for a role of the adrenergic nervous system in generalized anxiety disorder.

Authors:  Xiaobin Zhang; Joanna Norton; Isabelle Carrière; Karen Ritchie; Isabelle Chaudieu; Joanne Ryan; Marie-Laure Ancelin
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

Review 2.  The zebrafish subcortical social brain as a model for studying social behavior disorders.

Authors:  Yijie Geng; Randall T Peterson
Journal:  Dis Model Mech       Date:  2019-08-06       Impact factor: 5.758

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.